SMCV Assessment on Brain Swelling in Patients With SAH

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

198 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-04-01

Study Completion Date

2023-12-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Cerebral swelling is a major complication following aneurysmal subarachnoid hemorrhage.This study is a retrospective cohort aimed to predict the extent of brain swelling. Cerebral venous assessment can identify the risk of brain swelling and improve surgical outcomes.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Glymphatic Function and White Matter Integrity in Cerebral Venous Disorders

NCT07072663

Cerebral Venous Sinus Thrombosis

NOT_YET_RECRUITING

Inflammation and Coagulation Factors for Predicting Cerebral Edema After SAH

NCT06009016

Inflammation Coagulation and Hemorrhagic Disorders Cerebral Edema

UNKNOWN

The Prediction of Hemorrhage Transformation by Cerebral Autoregulation in AIS Patient After Endovascular Thrombectomy

NCT06361017

Acute Ischemic Stroke Endovascular Thrombectomy Dynamic Cerebral Autoregulation

ENROLLING_BY_INVITATION

Long-term Prognosis of Emergency Aneurysmal Subarachnoid Hemorrhage

NCT04785976

Aneurysmal Subarachnoid Hemorrhage

RECRUITING

Retrospective Cohort Study of Intracerebral Hemorrhage

NCT04803292

Intracerebral Hemorrhage

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Cerebral swelling is a major complication following aneurysmal subarachnoid hemorrhage (SAH).This study is a retrospective cohort aimed to predict the extent of brain swelling (BS). Cerebral venous assessment can identify the risk of cerebral swelling and improve surgical outcomes. This study is a retrospective cohort analysis. Cerebral venous angiography (CVA) will be adopted and the superficial middle cerebral vein (SMCVs) will be evaluated.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Aneurysm Subarachnoid Hemorrhage Brain Swelling

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Undeveloped venous group

patients with undeveloped cerebral venous

Aneurysm embolization

Intervention Type PROCEDURE

All patients underwent Aneurysm embolization surgery, the cerebral venous will be observed intraoperatively.

Well Developed venous group

patients with well-developed cerebral venous

Aneurysm embolization

Intervention Type PROCEDURE

All patients underwent Aneurysm embolization surgery, the cerebral venous will be observed intraoperatively.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Aneurysm embolization

All patients underwent Aneurysm embolization surgery, the cerebral venous will be observed intraoperatively.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

patients with anterior communicating aneurysm

Exclusion Criteria

Hunt-Hess grade I- patients with posterior communicating aneurysm, poor general condition or combined with pregnancy , malignant tumors were excluded.

Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No